Skip to main content

Month: April 2024

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) today announced that it and its direct subsidiaries have filed voluntary petitions for chapter 11 protection under the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of Texas. The company also announced a “stalking horse” agreement for the sale of Zokinvy® (lonafarnib) to Sentynl Therapeutics, Inc., a biopharmaceutical company focused on rare diseases. Under the terms of the “stalking horse” agreement, subject to court approval, Sentynl Therapeutics will pay up to $26.0 million, subject to certain purchase price adjustments, including per diem reductions if the...

Continue reading

Ferrellgas Encourages Customers to Locate Utility Lines Before Digging

LIBERTY, Mo., April 01, 2024 (GLOBE NEWSWIRE) — April is National Safe Digging Month, and Ferrellgas Partners, L.P. (OTC: FGPR) is reminding everyone to take a few extra steps before tackling any big outdoor project this spring. Ferrellgas’ top priority is safety, and that’s why the company believes it’s so important for homeowners to find out where utility lines run before they dig into the ground, so they don’t accidentally cut into them. Determining where utility lines run is easy! Homeowners can simply call 811 or refer to this state-by-state map to help them understand the regulations in their area. Then, they can set up an appointment with a representative who will come out to mark where their utility lines are. They usually spray paint the area or use small flags to show where the lines run. It’s important to note that the...

Continue reading

Security National Financial Corporation Reports Financial Results for the Year Ended December 31, 2023

SALT LAKE CITY, April 01, 2024 (GLOBE NEWSWIRE) — Security National Financial Corporation (SNFC) (NASDAQ symbol “SNFCA”) announced financial results for the year ended December 31, 2023. For the twelve months ended December 31, 2023, SNFC’s after-tax earnings from operations decreased 44% from $25,690,000 in 2022 to $14,495,000 in 2023, on a 18% decrease in revenues to $318,497,000. Scott Quist, Chairman of the Board, President, and Chief Executive Officer of SNFC, said, “2023 was a year where the financial balance of our company demonstrated itself. With the increasing interest rates and improving premium margins our life insurance business segment had its best operational year ever, earning $25,000,000. As death rates stabilized throughout 2023, and as we implemented renewed emphasis on operational efficiencies, our...

Continue reading

Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024

LAKEWOOD, Colo., April 01, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ending March 31, 2024 at approximately 8:00 A.M. Eastern time on Friday, May 24, 2024. About Mesa Laboratories, Inc. Mesa is a global leader in the design and manufacture of life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world. For more information about the Company, please visit our website at www.mesalabs.com.CONTACT: CONTACT: Gary Owens, President and CEO, or John Sakys, CFO, both...

Continue reading

NewtekOne, Inc. Hires Taylor Quinn as Chief Risk Officer

BOCA RATON, Fla., April 01, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT), announced today that it has hired Mr. Taylor Quinn as Senior Vice President, Chief Risk Officer for NewtekOne and Newtek Bank, N.A., effective today. Mr. Quinn comes to the Company as an established financial services executive with close to 15 years of experience in audit, finance, and risk management with a focus in the banking space. Most recently, Taylor was the Senior Vice President, Chief Audit Executive at Amalgamated Bank where he was responsible for independently assisting the audit committee of the board of directors in fulfilling their oversight responsibility by evaluating the design and effectiveness of Amalgamated Bank’s control environment. Further, Taylor developed and integrated audit and risk management frameworks...

Continue reading

NewtekOne, Inc. Announces Loan Closings for the First Quarter 2024

Record Loan Approvals Across All Loan Products in First Quarter 2024 Strong Growth in Lending and Deposits in the First Quarter 2024 BOCA RATON, Fla., April 01, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company” or “NewtekOne”) (NASDAQ: NEWT), announced today that its nationally chartered bank subsidiary, Newtek Bank, N.A., closed $207.7 million of SBA 7(a) loans for the three months ended March 31, 2024, which represents a 36.2% increase over $152.5 million of SBA 7(a) loans closed in the first quarter 2023. Newtek Bank and the Company’s non-bank subsidiaries closed $308.6 million of loans, across all loan products, for the three months ended March 31, 2024, which represents a 35.8% increase over $227.2 million for the same period in 2023. The Company also announced strong growth in its loan approval pipeline across all lending...

Continue reading

NewtekOne, Inc. Promotes Frank M. DeMaria to Chief Accounting Officer

BOCA RATON, Fla., April 01, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) has promoted Mr. Frank M. DeMaria to Executive Vice President, Chief Accounting Officer of NewtekOne effective as of March 29, 2024. Mr. DeMaria has been with NewtekOne since May of 2023 as Senior Vice President of Accounting and Finance. Frank brings a career’s worth of experience across many facets of financial holding company accounting and finance to this position. Frank’s prior experience includes being Senior Vice President & Controller at Flagstar Bank, N.A; Senior Vice President & Chief Accounting Officer at Amalgamated Financial Corp.; and Senior Manager at KPMG LLP, Audit Financial Services. Frank will report to M. Scott Price, Chief Financial Officer of NewtekOne. Our former Chief Accounting Officer, Nick Leger,...

Continue reading

CORRECTING and REPLACING NewtekOne, Inc. News Release

BOCA RATON, Fla., April 01, 2024 (GLOBE NEWSWIRE) — Today NewtekOne, Inc. (“NewtekOne”) timely filed its annual report on Form 10-K for the period ended December 31, 2023. The purpose of this press release is to update and replace NewtekOne’s press release dated March 5, 2024, which announced NewtekOne’s unaudited fourth quarter and full year 2023 financial results. NewtekOne, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results Full Year 2023 Basic Earnings per Share of $1.89 and Diluted Earnings per Share of $1.88 NewtekOne, Inc. (Nasdaq: NEWT), announced today its audited financial and operating results for the three and twelve months ended December 31, 2023. This is NewtekOne’s fourth quarter reporting, and third full quarter reporting, as a financial holding company following the Company’s January...

Continue reading

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company focused on gene editing technologies, are excited to announce their collaboration to advance the field of genome editing using Coastar’s red blood cell membrane derived carriers and SOHM’s ABBIE (A Binding Based Integrase Enzyme) genome editing technology. Genome editing, particularly through the use of CRISPR-Cas9 technology, has emerged as a groundbreaking approach...

Continue reading

APA Corporation Appoints Matthew Bob and Anya Weaving to Board of Directors

HOUSTON, April 01, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today announced the appointment of Matthew Bob and Anya Weaving to its board of directors. “We are very pleased to welcome Matthew and Anya to the APA board,” said Lamar McKay, APA’s nonexecutive board chair. “Matthew brings extensive executive and operational experience with U.S. onshore oil and gas companies in addition to his technical expertise. His knowledge of Callon will provide the board with valuable insight and guidance on the newly acquired company assets. Anya’s experience in the oil and gas industry as well as her background advising large cap energy companies will bring additional critical skills to the board. Her expertise in mergers and acquisitions and other financial transactions will support the board in evaluating future strategic opportunities....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.